HCA
RLAY icon

Harbor Capital Advisors’s Relay Therapeutics RLAY Stock Holding History

Harbor Capital Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,064
Closed -$419K – 839
2023
Q4 		$419K Sell
38,064
-3,128
-8% -$26.4K 0.08% 265
2023
Q3 		$346K Buy
41,192
+914
+2% +$9.83K 0.07% 281
2023
Q2 		$506K Buy
+40,278
New +$501K 0.1% 244

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Harbor Capital Advisors's RLAY Position: Q1 2024 in Review

Harbor Capital Advisors sold out of Relay Therapeutics (RLAY) in Q1 2024, closing a stake of 38,064 shares — an estimated $419K sold.

Harbor Capital Advisors first reported a position in RLAY in Q2 2023 and held it in 3 quarters. The position peaked at $506K in Q2 2023. 189 funds tracked by Wall St. Rank hold RLAY as of Q1 2024.

  • Harbor Capital Advisors reported no remaining Relay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 38,064 Relay Therapeutics shares in Q1 2024, an estimated $419K.
  • Harbor Capital Advisors first reported a position in Relay Therapeutics in Q2 2023 and held it in 3 quarters.
  • Harbor Capital Advisors's Relay Therapeutics position peaked at $506K in Q2 2023.
  • 189 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2024.

Based on Harbor Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.